Literature DB >> 9466786

Comparison of eight methods to detect vancomycin resistance in enterococci.

H P Endtz1, N Van Den Braak, A Van Belkum, W H Goessens, D Kreft, A B Stroebel, H A Verbrugh.   

Abstract

A collection of genetically unrelated vancomycin-resistant enterococci (VRE) including 50 vanA, 15 vanB, 50 vanC1, and 30 vanC2 VRE were used to evaluate the accuracy of eight currently available susceptibility test methods (agar dilution, disk diffusion, E-test, agar screen plate, Vitek GPS-TA and GPS-101, and MicroScan overnight and rapid panels). vanA VRE were detected by all methods. vanB VRE were often not detected by Vitek GPS-TA and MicroScan rapid (sensitivities, 47 and 53%, respectively), though the new Vitek GPS-101 was found to be a significant improvement. E-test and the agar screen were the only two methods detecting all VRE, including the vanC1/C2 VRE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466786      PMCID: PMC104587     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

2.  Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.

Authors:  H P Endtz; N van den Braak; A van Belkum; J A Kluytmans; J G Koeleman; L Spanjaard; A Voss; A J Weersink; C M Vandenbroucke-Grauls; A G Buiting; A van Duin; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

Review 3.  Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.

Authors:  M Michel; L Gutmann
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

Review 4.  Resistance to glycopeptides in enterococci.

Authors:  R Leclercq; P Courvalin
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

5.  What can we do about vancomycin-resistant enterococci?

Authors:  B E Murray
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

6.  Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci.

Authors:  F C Tenover; J M Swenson; C M O'Hara; S A Stocker
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

7.  Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp.

Authors:  J E Schulz; D F Sahm
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

8.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

9.  Vancomycin resistance gene vanC is specific to Enterococcus gallinarum.

Authors:  R Leclercq; S Dutka-Malen; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 10.  Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).

Authors: 
Journal:  Am J Infect Control       Date:  1995-04       Impact factor: 2.918

View more
  13 in total

1.  Limitations of vitek GPS-418 cards in exact detection of vancomycin-resistant enterococci with the vanB genotype.

Authors:  T Okabe; K Oana; Y Kawakami; M Yamaguchi; Y Takahashi; Y Okimura; T Honda; T Katsuyama
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  An Update on the Emergence of Glycopeptide Resistance in Enterococci.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 4.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Direct disk diffusion test using European Clinical Antimicrobial Susceptibility Testing breakpoints provides reliable results compared with the standard method.

Authors:  Sofia Stokkou; Gernot Geginat; Dirk Schlüter; Ina Tammer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

6.  Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.

Authors:  M Papadimitriou-Olivgeris; E Drougka; F Fligou; F Kolonitsiou; A Liakopoulos; V Dodou; E D Anastassiou; E Petinaki; M Marangos; K S Filos; I Spiliopoulou
Journal:  Infection       Date:  2014-08-21       Impact factor: 3.553

7.  Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.

Authors:  N van Den Braak; W Goessens; A van Belkum; H A Verbrugh; H P Endtz
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Evaluation of the revised MicroScan dried overnight gram-positive identification panel to identify Enterococcus species.

Authors:  P C Iwen; M E Rupp; P C Schreckenberger; S H Hinrichs
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  Evaluation of a novel automated chemiluminescent assay system for antimicrobial susceptibility testing.

Authors:  Isao Manome; Masanari Ikedo; Yoshihiko Saito; Keiko Kumura Ishii; Mitsuo Kaku
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Characterization of glycopeptide-resistant enterococci from a Swiss hospital.

Authors:  N Liassine; R Frei; I Jan; R Auckenthaler
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.